The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pet Veterinary Drug Market Research Report 2025
Synopsis
Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets.
The global Pet Veterinary Drug market was valued at US$ 8714.7 million in 2023 and is anticipated to reach US$ 12120 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 47%.
This report aims to provide a comprehensive presentation of the global market for Pet Veterinary Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Veterinary Drug.
Report Scope
The Pet Veterinary Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Veterinary Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Veterinary Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim International GmbH
Zoetis Animal Healthcare
Bayer AG
Merck Animal Health
Elanco Animal Health Inc.
Virbac Group
Ceva
Dechra Pharmaceuticals Plc
Vetoquinol
Orion Corporation
Segment by Type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Drug Stores
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Veterinary Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Veterinary Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets.
The global Pet Veterinary Drug market was valued at US$ 8714.7 million in 2023 and is anticipated to reach US$ 12120 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 47%.
This report aims to provide a comprehensive presentation of the global market for Pet Veterinary Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Veterinary Drug.
Report Scope
The Pet Veterinary Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Veterinary Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Veterinary Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim International GmbH
Zoetis Animal Healthcare
Bayer AG
Merck Animal Health
Elanco Animal Health Inc.
Virbac Group
Ceva
Dechra Pharmaceuticals Plc
Vetoquinol
Orion Corporation
Segment by Type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Drug Stores
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Veterinary Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Veterinary Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pet Veterinary Drug Market Overview
1.1 Product Overview and Scope of Pet Veterinary Drug
1.2 Pet Veterinary Drug Segment by Type
1.2.1 Global Pet Veterinary Drug Market Value Comparison by Type (2024-2030)
1.2.2 Anti-Infectives
1.2.3 Anti-Inflammatory
1.2.4 Parasiticides
1.2.5 Analgesics
1.2.6 Sedatives
1.2.7 Others
1.3 Pet Veterinary Drug Segment by Application
1.3.1 Global Pet Veterinary Drug Market Value by Application: (2024-2030)
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Drug Stores
1.4 Global Pet Veterinary Drug Market Size Estimates and Forecasts
1.4.1 Global Pet Veterinary Drug Revenue 2019-2030
1.4.2 Global Pet Veterinary Drug Sales 2019-2030
1.4.3 Global Pet Veterinary Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pet Veterinary Drug Market Competition by Manufacturers
2.1 Global Pet Veterinary Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pet Veterinary Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pet Veterinary Drug Average Price by Manufacturers (2019-2024)
2.4 Global Pet Veterinary Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet Veterinary Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Veterinary Drug, Product Type & Application
2.7 Pet Veterinary Drug Market Competitive Situation and Trends
2.7.1 Pet Veterinary Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Veterinary Drug Players Market Share by Revenue
2.7.3 Global Pet Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Veterinary Drug Retrospective Market Scenario by Region
3.1 Global Pet Veterinary Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pet Veterinary Drug Global Pet Veterinary Drug Sales by Region: 2019-2030
3.2.1 Global Pet Veterinary Drug Sales by Region: 2019-2024
3.2.2 Global Pet Veterinary Drug Sales by Region: 2025-2030
3.3 Global Pet Veterinary Drug Global Pet Veterinary Drug Revenue by Region: 2019-2030
3.3.1 Global Pet Veterinary Drug Revenue by Region: 2019-2024
3.3.2 Global Pet Veterinary Drug Revenue by Region: 2025-2030
3.4 North America Pet Veterinary Drug Market Facts & Figures by Country
3.4.1 North America Pet Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pet Veterinary Drug Sales by Country (2019-2030)
3.4.3 North America Pet Veterinary Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pet Veterinary Drug Market Facts & Figures by Country
3.5.1 Europe Pet Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pet Veterinary Drug Sales by Country (2019-2030)
3.5.3 Europe Pet Veterinary Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Veterinary Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pet Veterinary Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Pet Veterinary Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pet Veterinary Drug Market Facts & Figures by Country
3.7.1 Latin America Pet Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pet Veterinary Drug Sales by Country (2019-2030)
3.7.3 Latin America Pet Veterinary Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Veterinary Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pet Veterinary Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pet Veterinary Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pet Veterinary Drug Sales by Type (2019-2030)
4.1.1 Global Pet Veterinary Drug Sales by Type (2019-2024)
4.1.2 Global Pet Veterinary Drug Sales by Type (2025-2030)
4.1.3 Global Pet Veterinary Drug Sales Market Share by Type (2019-2030)
4.2 Global Pet Veterinary Drug Revenue by Type (2019-2030)
4.2.1 Global Pet Veterinary Drug Revenue by Type (2019-2024)
4.2.2 Global Pet Veterinary Drug Revenue by Type (2025-2030)
4.2.3 Global Pet Veterinary Drug Revenue Market Share by Type (2019-2030)
4.3 Global Pet Veterinary Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pet Veterinary Drug Sales by Application (2019-2030)
5.1.1 Global Pet Veterinary Drug Sales by Application (2019-2024)
5.1.2 Global Pet Veterinary Drug Sales by Application (2025-2030)
5.1.3 Global Pet Veterinary Drug Sales Market Share by Application (2019-2030)
5.2 Global Pet Veterinary Drug Revenue by Application (2019-2030)
5.2.1 Global Pet Veterinary Drug Revenue by Application (2019-2024)
5.2.2 Global Pet Veterinary Drug Revenue by Application (2025-2030)
5.2.3 Global Pet Veterinary Drug Revenue Market Share by Application (2019-2030)
5.3 Global Pet Veterinary Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim International GmbH
6.1.1 Boehringer Ingelheim International GmbH Corporation Information
6.1.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.1.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Portfolio
6.1.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.2 Zoetis Animal Healthcare
6.2.1 Zoetis Animal Healthcare Corporation Information
6.2.2 Zoetis Animal Healthcare Description and Business Overview
6.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis Animal Healthcare Pet Veterinary Drug Product Portfolio
6.2.5 Zoetis Animal Healthcare Recent Developments/Updates
6.3 Bayer AG
6.3.1 Bayer AG Corporation Information
6.3.2 Bayer AG Description and Business Overview
6.3.3 Bayer AG Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer AG Pet Veterinary Drug Product Portfolio
6.3.5 Bayer AG Recent Developments/Updates
6.4 Merck Animal Health
6.4.1 Merck Animal Health Corporation Information
6.4.2 Merck Animal Health Description and Business Overview
6.4.3 Merck Animal Health Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Animal Health Pet Veterinary Drug Product Portfolio
6.4.5 Merck Animal Health Recent Developments/Updates
6.5 Elanco Animal Health Inc.
6.5.1 Elanco Animal Health Inc. Corporation Information
6.5.2 Elanco Animal Health Inc. Description and Business Overview
6.5.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Elanco Animal Health Inc. Pet Veterinary Drug Product Portfolio
6.5.5 Elanco Animal Health Inc. Recent Developments/Updates
6.6 Virbac Group
6.6.1 Virbac Group Corporation Information
6.6.2 Virbac Group Description and Business Overview
6.6.3 Virbac Group Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Virbac Group Pet Veterinary Drug Product Portfolio
6.6.5 Virbac Group Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Pet Veterinary Drug Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Dechra Pharmaceuticals Plc
6.8.1 Dechra Pharmaceuticals Plc Corporation Information
6.8.2 Dechra Pharmaceuticals Plc Description and Business Overview
6.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Portfolio
6.8.5 Dechra Pharmaceuticals Plc Recent Developments/Updates
6.9 Vetoquinol
6.9.1 Vetoquinol Corporation Information
6.9.2 Vetoquinol Description and Business Overview
6.9.3 Vetoquinol Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vetoquinol Pet Veterinary Drug Product Portfolio
6.9.5 Vetoquinol Recent Developments/Updates
6.10 Orion Corporation
6.10.1 Orion Corporation Corporation Information
6.10.2 Orion Corporation Description and Business Overview
6.10.3 Orion Corporation Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Orion Corporation Pet Veterinary Drug Product Portfolio
6.10.5 Orion Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Veterinary Drug Industry Chain Analysis
7.2 Pet Veterinary Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Veterinary Drug Production Mode & Process
7.4 Pet Veterinary Drug Sales and Marketing
7.4.1 Pet Veterinary Drug Sales Channels
7.4.2 Pet Veterinary Drug Distributors
7.5 Pet Veterinary Drug Customers
8 Pet Veterinary Drug Market Dynamics
8.1 Pet Veterinary Drug Industry Trends
8.2 Pet Veterinary Drug Market Drivers
8.3 Pet Veterinary Drug Market Challenges
8.4 Pet Veterinary Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
